← Back to Search

Beef

Burger Types for Inflammation

N/A
Waitlist Available
Led By Stephan van Vliet, PhD
Research Sponsored by Utah State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately before meal
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how different types of meat (regular beef, grass-fed beef, plant-based burger) affect inflammation and health markers in overweight or obese middle-aged adults. Blood samples are taken to measure these effects.

Who is the study for?
This trial is for overweight or obese adults aged 30-60 who have been weight stable in the past 3 months. Participants must not be heavy drinkers, pregnant, lactating, allergic to soy, smokers, or have certain health conditions like diabetes or heart failure. They should not be on medications affecting inflammation and can't have had a recent COVID vaccine.
What is being tested?
The study compares the effects of consuming a grain-fed beef hamburger, grass-fed beef hamburger, or an Impossible Burger on blood markers of inflammation and metabolism. Each participant will eat each type of burger on separate visits with blood samples taken before and after meals at specific intervals.
What are the potential side effects?
There are no direct side effects from eating the burgers mentioned in the study; however, participants may experience discomfort from frequent blood draws such as bruising at the needle site.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from fasting concentrations after eating.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from fasting concentrations after eating. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Inflammatory cytokine biomarker (C-reactive protein) concentrations in plasma samples
Inflammatory cytokine biomarker (IL-6) concentrations in plasma samples
Inflammatory cytokine biomarker (TNF-alpha) concentrations in plasma samples
+2 more
Secondary study objectives
Mood Questionnaires
Satiety Questionnaire
Taste Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

6Treatment groups
Active Control
Group I: Sequence 6: Grass-Fed, Impossible, Grain-FedActive Control3 Interventions
On the first visit, a grass-fed beef burger (250 grams) will be consumed. On the second visit, an Impossible BurgerTM (250 grams) will be consumed. On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Group II: Sequence 5: Grain-Fed, Impossible, Grass-FedActive Control3 Interventions
On the first visit, a grain-fed beef burger (250 grams) will be consumed. On the second visit, an Impossible BurgerTM (250 grams) will be consumed. On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Group III: Sequence 3: Impossible, Grass-Fed, Grain-FedActive Control3 Interventions
On the first visit, an Impossible BurgerTM (250 grams) will be consumed. On the second visit, a grass-fed beef burger (250 grams) will be consumed. On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Group IV: Sequence 4: Impossible, Grain-Fed, Grass-FedActive Control3 Interventions
On the first visit, an Impossible BurgerTM (250 grams) will be consumed. On the second visit, a grain-fed beef burger (250 grams) will be consumed. On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Group V: Sequence 1: Grain-Fed, Grass-Fed, ImpossibleActive Control3 Interventions
On the first visit, a grain-fed beef burger (250 grams) will be consumed. On the second visit, a grass-fed beef burger (250 grams) will be consumed. On the third visit, an Impossible BurgerTM (250 grams) will be consumed.
Group VI: Sequence 2: Grass-Fed, Grain-Fed, ImpossibleActive Control3 Interventions
On the first visit, a grass-fed beef burger (250 grams) will be consumed. On the second visit, a grain-fed beef burger (250 grams) will be consumed. On the third visit, an Impossible BurgerTM (250 grams) will be consumed.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for inflammation often target the reduction of inflammatory markers and the modulation of metabolite profiles in the blood. Dietary interventions, such as the consumption of different types of meat (grain-fed beef, grass-fed beef) and plant-based alternatives (Impossible Burger), can influence these markers. For instance, grass-fed beef may have a different fatty acid profile compared to grain-fed beef, potentially leading to lower levels of pro-inflammatory markers. Plant-based alternatives might offer benefits through higher levels of phenolics and other anti-inflammatory compounds. These dietary choices matter for inflammation patients as they can modulate the body's inflammatory response, potentially reducing chronic inflammation and associated risks of diseases such as cardiovascular conditions and metabolic disorders.

Find a Location

Who is running the clinical trial?

Duke UniversityOTHER
2,458 Previous Clinical Trials
2,969,413 Total Patients Enrolled
12 Trials studying Inflammation
3,517 Patients Enrolled for Inflammation
United States Department of Agriculture (USDA)FED
100 Previous Clinical Trials
286,643 Total Patients Enrolled
6 Trials studying Inflammation
314 Patients Enrolled for Inflammation
Utah State UniversityLead Sponsor
45 Previous Clinical Trials
4,722 Total Patients Enrolled
5 Trials studying Inflammation
156 Patients Enrolled for Inflammation
Stephan van Vliet, PhDPrincipal InvestigatorUtah State University
1 Previous Clinical Trials
21 Total Patients Enrolled

Media Library

Grain-Fed Beef Hamburger (Beef) Clinical Trial Eligibility Overview. Trial Name: NCT05690061 — N/A
Inflammation Research Study Groups: Sequence 6: Grass-Fed, Impossible, Grain-Fed, Sequence 5: Grain-Fed, Impossible, Grass-Fed, Sequence 3: Impossible, Grass-Fed, Grain-Fed, Sequence 4: Impossible, Grain-Fed, Grass-Fed, Sequence 1: Grain-Fed, Grass-Fed, Impossible, Sequence 2: Grass-Fed, Grain-Fed, Impossible
Inflammation Clinical Trial 2023: Grain-Fed Beef Hamburger Highlights & Side Effects. Trial Name: NCT05690061 — N/A
Grain-Fed Beef Hamburger (Beef) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05690061 — N/A
~13 spots leftby Dec 2025